Norges Bank Alvotech Transaction History
Norges Bank
- $772 Billion
- Q2 2025
A detailed history of Norges Bank transactions in Alvotech stock. As of the latest transaction made, Norges Bank holds 180,000 shares of ALVO stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180,000Holding current value
$1.64 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALVO
# of Institutions
52Shares Held
16.4MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.23MShares$38.5 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$24.6 Million14.1% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$14.2 Million0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.39MShares$12.6 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$12 Million11.48% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.26B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...